Vaxxinity OverviewVaxxinity Cost of Revenue
Cost of Revenue analysis for VAXX.
Quarterly Cost of Revenue
$456000.00
↓ 15.56% YoY
As of Dec 31, 2023
Annual Cost of Revenue (TTM)
$2.23M
↑ 65.36% YoY
Trailing 12 months ending Dec 31, 2023
Vaxxinity OverviewCost of Revenue analysis for VAXX.
As of Dec 31, 2023
Trailing 12 months ending Dec 31, 2023